Inactive Instrument

MERCK Kommanditgesellschaft auf Aktien Share Price Other OTC

Equities

MKKGY

US5893392093

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2.13TCr 2.31TCr 1,92500Cr Sales 2025 * 2.25TCr 2.44TCr 2,03600Cr Capitalization 7.27TCr 7.9TCr 6,58100Cr
Net income 2024 * 295.8Cr 321.46Cr 27TCr Net income 2025 * 345.7Cr 375.69Cr 31TCr EV / Sales 2024 * 3.8 x
Net Debt 2024 * 817.1Cr 887.98Cr 74TCr Net Debt 2025 * 506.92Cr 550.9Cr 46TCr EV / Sales 2025 * 3.46 x
P/E ratio 2024 *
24.3 x
P/E ratio 2025 *
20.6 x
Employees -
Yield 2024 *
1.36%
Yield 2025 *
1.45%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on MERCK Kommanditgesellschaft auf Aktien

Managers TitleAgeSince
Chief Executive Officer 62 13/20/13
Director of Finance/CFO 56 01/14/01
Director of Finance/CFO 53 26/19/26
Members of the board TitleAgeSince
Director/Board Member 75 09/14/09
Director/Board Member - -
Chairman 67 26/19/26
More insiders
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW